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Low toxic graphene quantum dot (GQD) was synthesized by pyrolyzing citric acid in alkaline solution and
characterized by ultraviolet–visible (UV–vis) spectroscopy, X-ray diffraction (XRD), atomic force micro-
scopy (AFM), spectroﬂuorimetery and dynamic light scattering (DLS) techniques. GQD was used for
electrode modiﬁcation and electro-oxidation of doxorubicin (DOX) at low potential. A substantial de-
crease in the overvoltage (0.56 V) of the DOX oxidation reaction (compared to ordinary electrodes) was
observed using GQD as coating of glassy carbon electrode (GCE). Differential pulse voltammetry was used
to evaluate the analytical performance of DOX in the presence of phosphate buffer solution (pH 4.0) and
good limit of detection was obtained by the proposed sensor. Such ability of GQD to promote the DOX
electron-transfer reaction suggests great promise for its application as an electrochemical sensor.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Graphene quantum dots (GQDs) are nanometer-sized frag-
ments of graphene. GQDs are a kind of 0D material with char-
acteristics derived from both graphene and carbon dots (CDs) [1].
Taking advantages of the electrochemical properties similar to
those of graphene, GQDs are widely used as a kind of suitable
electrode material, not only in fuel cells [2], supercapacitors [3,4]
and photovoltaic cells [5], but also in the ﬁeld of electrochemical
sensors [6,7]. Furthermore, GQDs of tunable sizes, i.e., 2.270.3,
2.670.2, and 370.3 nm, can act as multivalent redox species
using cyclic voltammetry (CV) and differential pulse voltammetry
(DPV) measurements, and present exciting opportunities for
building electrochemical sensors [8]. More recently, GQDs have
been used in the area of bioanalysis [6,7,9]. However, their appli-
cations in the analytical ﬁeld have not been explored until now.on and hosting by Elsevier B.V. Th
University.
Center, Tabriz University of
m,
shadjou@gmail.com,Due to their unique properties, sensors based on GQDs can achieve
a high level of performance.
Toxicity of nanomaterials is one of the major challenges of their
applications in science and biotechnology. GQDs have the potential
to be remarkably successful in the ﬁeld of nanobiotechnology due
to their excellent opto-electrical properties and extremely low
cytotoxicity [10–14]. Currently used quantum dots (CdS, PbS, ZnS,
ZnSe, HgTe, Ag2S, Ag2Se, CuInS2, CuInSe2, InAs and InP) are com-
posed of toxic metals which may cause problems for their use in
biological systems. However, GQDs are increasingly being em-
ployed to provide more efﬁcient and less toxic alternatives than
currently used quantum dots [15–17]. Studies on human breast
cancer have shown that GQDs can easily ﬁnd their way into the
cytoplasm and do not interfere with cell proliferation, which in-
dicates that they are non-toxic materials [15–17].
Furthermore, GQDs expand contact area with the analyte,
which increases the electrochemical active surface area to interact
with some electroactive analytes. Since geometric surface area is a
very important parameter in electrochemistry, modiﬁcation of
different substrates (such as glass, carbon, graphite etc.) by GQDs
can increase the rate of electrochemical reaction.
Herein, we developed a highly sensitive electrochemical sensor
based on GQD in order to determine low concentration of doxor-
ubicin (DOX) in biological samples. To the best of our knowledge,is is an open access article under the CC BY-NC-ND license
N. Hashemzadeh et al. / Journal of Pharmaceutical Analysis 6 (2016) 235–241236this is the ﬁrst report on the determination of DOX based on its
direct electrochemical oxidation by graphene quantum dot-glassy
carbon electrode (GQD-GCE). Using this system, the detection of
low quantities of DOX was realized using differential pulse vol-
tammetry (DPV). The electrode has an ultra-low detection limit
during DOX electrooxidation. The electrode for DOX electro-
oxidation has demonstrated its excellent performance. Further-
more, the proposed sensor (GQD-GCE) was successfully used to
detect DOX in human plasma, cerebrospinal ﬂuid, and urine
samples.2. Experimental
2.1. Chemicals and reagents
All chemicals were purchased from Merck (Darmstadt, Ger-
many) and used without further puriﬁcation. Alumina slurry was
purchased from Beuhler (Illinois, USA) and DOX was purchased
from Exir Nano Sina Company (Tehran, Iran). All solutions were
prepared with deionized water. The stock solution of DOX (0.18 M)
was prepared by dissolving an accurate amount of DOX in an ap-
propriate volume of 0.02 M phosphate buffer solution (PBS),
pH¼4.0 (which was also used as supporting electrolyte), and then
stored in the dark place at 4 °C. Additional dilute solutions were
prepared daily by accurate dilution just before use. Also the other
stock solutions were prepared by dissolving an accurate amount
equal to molecular weight of each one in 1000 mL deionized water
and then all stored in the dark place at 4 °C.
2.2. Preparation of human plasma samples
Human plasma samples were obtained from the Iranian Blood
Transfusion Research Center (Tabriz, Iran) and aliquots were
transferred into microtubes and frozen at 4 °C until analysis.
Human plasma samples frozen at 4 °C were thawed at room
temperature daily and vortexed to ensure homogeneity. After
thawing the samples gently, an aliquot of 2 mL of this sample was
spiked with DOX, and then acetonitrile with the volume ratio of
2:1 (acetonitrile:plasma) was added to precipitate plasma pro-
teins. The mixture was centrifuged for 10 min at 6000 rpm to se-
parate residues of plasma proteins. Approximately, 2 mL of su-
pernatant was taken and added into supporting electrolyte to
reach a total volume of 10 mL.
2.3. Apparatuses and methods
Electrochemical measurements were carried out in a conven-
tional three-electrode cell (from Metrohm) powered by an elec-
trochemical system comprising of AUTOLAB system with
PGSTAT302N (Eco Chemie, Utrecht, The Netherlands). The system
was run on a PC using NOVA 1.7 software. Saturated Ag/AgCl was
used as the reference electrode and the counter electrode (also
known as auxiliary electrode), which is usually made of an inert
material, platinum. All potentials were measured with respect to
the Ag/AgCl which was positioned as close to the working elec-
trode as possible by means of a luggin capillary. GCE (Azar elec-
trode Co., Urmia, Iran) was used as the working electrode. Atomic
force microscopy (AFM) experiments were performed in a contact
mode by Nanowizard AFM (JPK Instruments AG, Berlin, Germany)
mounted on Olympus Invert Microscope IX81 (Olympus Co., To-
kyo, Japan). The transmission electron microscope (TEM) images
were obtained on Leo 906, Zeiss (Germany). UV–vis spectroscopy
was performed by Spectro UV–vis 2502 (Cecil, Cambridge, UK).
X-ray powder diffraction (XRD) measurements were performed
using Siemens, D500 (Germany). Dynamic light scattering (DLS)was obtained using Malvern 3500 ZS. Spectroﬂuorimetery test was
performed using Jasco, FP-750 (Tokyo, Japan).3. Results and discussion
3.1. Synthesis of GQDs
An easy bottom-up method was used for the preparation of
GQDs. At ﬁrst, GQDs were synthesized by pyrolyzing citric acid and
dispersing the carbonized products into alkaline solutions [18].
Brieﬂy, 2 g of citric acid was put into a beaker and heated to 200 °C
by a heating mantle until the citric acid changed to an orange li-
quid. Then, for preparing GQDs, 100 mL of 10 mg/mL NaOH solu-
tion was added into the orange homogenous liquid dropwise with
continuous stirring. The obtained GQD solution was stable for at
least one month at 4 °C. It is important to point out that the time
of synthesis process of GQD was 30 min.
3.2. Characterization of GQDs
Fig. 1A shows the AFM image of synthesized GQDs. The corre-
sponding AFM image shows a single GQD monolayer thin ﬁlm. As
can be seen in Fig. 1B, 90% of the particles represented dark brown
color, which was assigned to a size range below 10 nm. Further-
more, the DLS study represented hydrodynamic sizes of GQDs
with size distribution of (574) nm (Fig. 2A) conﬁrming the AFM
results.
The XRD pattern of GQD (Fig. 3A) shows a broad peak centered
at around 25θ (0.36 nm), suggesting that the electrochemical
process has more active sites along the surfaces of GQD, and the
shifted peak to a higher degree, compared with the graphene,
indicated that carbonization of citric acid produced graphite
structures which had a more compact interlayer spacing than the
original graphene.
The UV–vis absorption spectra of GQD (Fig. 2B) illustrate typical
absorption of graphene derivatives in the UV region (200–300 nm)
with an intensive peak at 340 nm and also a peak at 210 nm.
Fig. 3B shows ﬂuorescence spectra of the GQD dispersed in water
at room temperature. The GQDs have a broad absorption from 400
to 600 nm. The maximum emission of 480 nm was obtained
with an excitation wavelength of 400 nm. Also when the excitation
wavelength changed from 340 to 420 nm, the maximum peaks
were constant. This could be explained by the uniformity both in
the size and the surface state of those sp2 clusters contained in
GQD which was responsible for the ﬂuorescence of GQD.
3.3. Preparation of bare and GQDs modiﬁed electrodes
GCE (2 mm in diameter) was polished to a mirror-like ﬁnish
with 0.3 and 0.05 mm alumina slurry and then thoroughly rinsed
with double distilled water. Then it was successively sonicated in
acetone and double distilled water and was allowed to dry at room
temperature. A total of 30 μL of GQDs with the concentration of
3 mg/mL was dropped on the surface of electrodes pretreated and
allowed to dry for 24 h at 4 °C in a dark place. Then the modiﬁed
electrodes were rinsed with double distilled water 2 or 3 times
and the GQDs modiﬁed electrodes were obtained and stored at
4 °C until use.
3.4. Electrochemical behavior
In order to verify the electrocatalytic activity of the modiﬁed
electrode (GQD-GCE) for determination of DOX, the electro-
chemical experiments in the presence of DOX were carried out.
Fig. 4 shows cyclic voltammograms (CVs) of bare GCE and
Fig. 1. The AFM (A) and TEM (B) images of GQD.
Fig. 2. (A) DLS analysis and (B) UV–vis absorption of GQD.
Fig. 3. (A) XRD pattern of GQD and (B) ﬂuorescence spectra of GQD.
N. Hashemzadeh et al. / Journal of Pharmaceutical Analysis 6 (2016) 235–241 237modiﬁed GQD-GCE in the absence and presence of DOX where
potential sweep rate of 100 mV/s was employed. CVs show that
using GQD-GCE and GCE one pair of redox peaks appeared (Fig. 4).
The comparison of recorded CVs in the absence and presence of
DOX shows a new anodic peak at 0.56 V on the surface of GQD-
GCE. The larger lowering of the overvoltage (0.56 V) observed in
the presence of GQD clearly indicated its essential role in the ob-
served electrocatalytic behavior. These results indicated that GQDs
ﬁlm could accelerate the rate of electron transfer of DOX and had
good electrocatalytic activity for redox reaction of DOX. Therefore,
GQD is a suitable mediator to shuttle electron between DOX and
Fig. 4. Cyclic voltammograms of bare GCE and GQD-GCE in the absence and pre-
sence of DOX (0.18 mM) in PBS (pH 4.0). Potential sweep rate: 100 mV/s.
Fig. 5. (A) Variation of peak current versus amounts of GQD (20, 25, 30, 35 and
45 mL) in PBS pH 4.0 (n¼3); (B) Inﬂuence of PBS pH (3, 4, 5, 6 and 7) on the oxi-
dation peak current; (C) Plot of the Ep versus pH for the GQD-GCE in PBS solution.
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following electron exchange with DOX. This observation is also
linked to the high conductivity and inherent ability of GQD. That
might be related to the excellent properties of GQD such as high
speciﬁc surface area and electrical conductivity.
3.5. Effect of modiﬁer amount and pH on the response of GQD-GCE
As shown in Fig. 5A, the ﬁrst step of modiﬁcation had a sa-
turation value for the amount of GQDs on the surface of the GCE.
The peak current increased with increased amounts of GQDs (20–
45 μL). A higher concentration of GQDs showed a decrease in peak
current. This is presumably due to the reduction of conductivity of
the sensor due to saturation of surface. Consequently, 30 μL of
GQDs was chosen as an optimal concentration.
Another important factor inﬂuencing the ﬁnal sensing of the
target molecules is pH. In this study, pH values from 3.0 to
7.0 were tested with no substantial differences in sensing peak
currents under different pH conditions and pH 4.0 was adopted for
sensing (Fig. 5B).
On the other hand, the anodic peak potential of DOX shifted
toward negative with an increase in pH (Fig. 5C). These results
indicated that the protons took part in their electrode reaction
processes. The peak potential (Ep) moved in negative direction
with pH rising and they showed such relationship as Ep(DOX)¼
0.0625pH þ0.473.
The slope of the plot of Ep(Ag/AgCl) versus pH was approximately
0.0625 V (R2¼0.9185). It was therefore deduced that both peaks
correspond to irreversible processes involving two electrons and
two protons.
This conclusion is in accordance with the known electro-
chemical reactions of DOX as shown in other investigation. It has
been known that DOX can be oxidized via two electrons and two
proton processes as shown in Scheme 1.3.6. Inﬂuence of scan rate on the electrooxidation of DOX using GQD-
GCE
The effect of the scan rate on DOX electrooxidation was in-
vestigated in the range of 2–1000 mV/s using CV (Fig. 6A). A linear
relationship was obtained between the peak current and the
square root of the scan rate (v1/2) in the range of 100–1000 mV/s,
which revealed that the oxidation of DOX was an adsorption-controlled step (Fig. 6A). Two approaches widely used to study the
reversibility of reactions and to determine whether a reaction is
adsorption or diffusion controlled consist of the analyses of de-
pendences: peak current (Ip) vs. v1/2 and ln Ip vs. ln v [19–21].
Fig. 6B shows these plots for the oxidation peak of DOX in 0.1 M
PBS. For reversible or irreversible systems without kinetic com-
plications, Ip varies linearly with v1/2, intercepting the origin. Al-
though the plot of Ip on v1/2 presented in Fig. 6B is linear
(R2¼0.9904), it does not cross the origin of the axes. This is
characteristic for the electrodic process preceded by electro-
chemical reaction and followed by a homogenous chemical reac-
tion. In the scan rate range from 100 to 1000 mV/s, Ip of DOX
electrooxidation depends linearly on square root of the scan rate
(v) and is described by the following equation:
Ip¼0.0306v1/2 [(mV/s)1/2 mA]þ0.0188 mA (R2¼0.9904).
This dependence crosses the origin (Fig. 6C), which suggests
that the electrode process of DOX electrooxidation is controlled by
diffusion. On the other hand, dependence of ln Ip on ln v is linear
(Fig. 6C) and described by the following equation:
ln Ip¼{0.4967ln v (V/s)}0.006 mA (R2¼0.9914).
Its slope is 0.4967, which indicates diffusion-control of the
electrode process. A slope close to 0.5 is expected for diffusion-
controlled electrode processes and close to 1.0 for adsorption-
controlled processes [19–21].
Scheme 1. Tentative mechanism of DOX on GQD-GCE.
Fig. 6. (A) CVs of GQD-GCE in the presence of 0.1 M PBS (pH 4.0) and 8 mM of DOX in different scan rates (from inner to outer): 20–1000 mV/s, respectively; (B) Dependence
of anodic peak current (Ip) on the square root of potential scan rate (v); (C) Dependence of anodic peak current on the potential scan rate in double logarithm coordinates in
the presence of 0.1 M PBS (pH 4.0) at GQD-GCE.
Fig. 7. DPVs of DOX (36109, 18109, 9109, 7109, 451010 and
181010 M) in PBS pH¼4.0 (n¼3). Inset: Calibration curve of DOX in spiked
human plasma samples.
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In order to develop a voltammetric method for DOX determi-
nation, we selected the DPV mode, because the peaks are sharper
and better deﬁned at lower concentration of DOX than those ob-
tained by CV, with a lower background current, resulting in im-
proved resolution. According to the obtained results, it was pos-
sible to apply this technique to the quantitative analysis of DOX. As
mentioned previously, the PBS of pH 4.0 was selected as the
supporting electrolyte for the quantiﬁcation of DOX. The max-
imum peak was observed approximately at 0.56 V for DOX by
DPV analysis. As shown in Fig. 7, the peak current increased lin-
early with the increased concentration of DOX.
The analytical responses of the modiﬁed electrode toward the
electroanalytical determination of DOX in human plasma samples
are listed in Table 1. The proposed method had suitable limit of
detection (LOD), wide linear range and good stability compared
with those of other methods. This method was checked with re-
spect to linearity (R2¼0.9971), inter-day precision (3.33% RSD),
intra-day precision (5.03% RSD) and accuracy.
3.8. Repeatability and long-term stability of the electrode
An extremely attractive feature of the GQD-modiﬁed electrodes
is their highly stable voltammetric DOX response. The stability of
the electrode was determined daily (inter-day) and over onemonth (intra-day). The obtained RSD% values are less than 1% for
inter-day analysis and less than 10% for intra-day determinations
up to 10 days. The precision results were not favourable for more
than 7 days.
Table 1
Analytical parameters obtained for determination of DOX on GQD-GCE in human plasma.
Analyte Linear range (μM) Correlation coefﬁcient (R2) Therapeutic range (mg/m2) LOD (μM) LOQ (μM) Precision (RSD, %)
Inter-day Intra-day
DOX 0.018–3.600 0.9971 60–75 0.016 0.050 3.33 5.03
Table 2
Recovery of DOX in spiked human plasma samples.
Conc. added (μM) Conc. found (μM) Recovery (%) SD (n¼3)
2.76105 2.48105 90 3.48104
1.84105 1.58105 86 1.10103
9.20106 1.08105 118 8.41104
Table 3
Determination of DOX in patient human plasma samples.
No. Gender Age (year)/
body
surface (m2)
Administered
dose (mg)
Sampling
time
Concentration
(μM)
1 Male 27/1.61 35 13 h 3.66108
2 Male 57/1.05 64 5 min 6.79108
3 Male 34/1.84 120 5 min 1.67107
4 Male 18/1.65 120 5 min 1.59107
5 Female 42/1.06 80 5 min 6.27108
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In order to evaluate the selectivity of the developed DPV pro-
cedure, the effects of various interferences were examined. Con-
siderable interference can be caused by co-existing surface active
compounds capable of competing with the analytes of interest for
the adsorption site on the electrode surface, resulting in decreased
or increased peak height. The competitive co-adsorption inter-
ference was evaluated in the presence of various substances
usually in biological ﬂuids. For these investigations, different in-
terfering species including glucose, cysteine amino acid, ascorbic
acid and uric acid were added at 1 mM concentration. The addition
of glucose caused DPV peak current to increase by about 47% in
comparison with DOX. Apparently, signal decrease effects wereTable 4
Comparison of the proposed electrochemical sensor for determination of DOX with som
Electrode Method Li
Silver-amalgam ﬁlm SWVa and AdSWVb 0.
Thiol base sol–gel (TBSol–Gel) modiﬁed gold electrode EISc and CV 4.
Nano-TiO2/naﬁon composite ﬁlm/GCE DPV 5.
CD-GNs/GCE DPV 10
CPEd DCVe and DPV –
CPE DPV 0.1
CPE DPV –
CPE DPV –
Micro-voltammetry DPV –
PS/Fe3O4-GO-SO3H/GCE DPV 0.
0.
0.
GQD-GCE DPV 0.
a SWV: Cathodic square-wave voltammetry.
b AdSWV: adsorptive square wave voltammetry.
c EIS: Electrochemical impedance spectroscopy.
d CPE: carbon paste electrode.
e DCV: Direct current voltammetry.caused by distortion. In contrast, the addition of cysteine amino
acid in the drug solution caused the DPV response of the drug to
increase by about 13%. Also, the addition of glucose caused DPV
peak current to increase by about 10% in comparison with DOX. On
the other hand, the addition of uric acid in the drug solution
caused the DPV response of the drug to decrease by about 10%.
According to the results and the US Food and Drug Administration
(US FDA) guideline, only glucose has the obvious change in DOX
electroanalytical studies.
3.10. Recovery study
Applicability of the GQD-GCE was examined for the determi-
nation of DOX in human plasma samples. The high sensitivity of
the sensor allows the determination of DOX in spiked human
plasma samples. The recovery of the analytes was measured by
spiking DOX into highly diluted plasma samples. The DPVs were
recorded after the plasma was spiked with various amounts of
DOX within the working concentration range. Recoveries were
found in the range of 90%–118% (Table 2).
The efﬁciency of the electrode was investigated with determi-
nation of the DOX concentration in real human plasma samples.
These samples were collected after the drug administration. The
plasma samples were obtained from patients receiving DOX who
had signed consent forms approved by the Ethic Committee, Tabriz
University of Medical Sciences, Iran. The results are listed in
Table 3.
The comparison of the proposed method with some of other
electrochemical reports for the determination of DOX is summar-
ized in Table 4 [22–31]. The analytical parameters of the proposed
electrochemical sensor such as LOD, matrix type and linear con-
centration range are better than or even comparable with the re-
ported data in the literature for electrochemical detection of DOX
with different modiﬁed electrodes.
Several methods have been reported for determination of DOX
in biological matrix, and the results indicate that the modiﬁede other reports.
near range(μM) LOD (μM) Matrix Ref.
0086–0.10283 0.00989 Human urine [22]
0–8 1.5 – [23]
0–2.0 1000 – [24]
–0.2 100 – [25]
0.8 (DCV) – [26]
0.06 (DPV)
–10 0.01 Human urine [27]
0.001 – [27]
0.00033 – [29]
0.001 Chinese hamster ovary cells [30]
043–3.5 0.0049 Plasma [31]
026–3.5 0.0043 Urine
86–13.0 0.014 Cerebrospinal ﬂuid
018–3.6 0.016 Human plasma This work
N. Hashemzadeh et al. / Journal of Pharmaceutical Analysis 6 (2016) 235–241 241electrode can be used for detection and determination of DOX
without any extraction steps. In most cases, the resulting LODs
were signiﬁcantly more than that of the proposed method. The
reported silver-amalgam ﬁlm [22] presents low LOD value in
comparison with these methods. Although dynamic linearity
range of the proposed method is not as wide as the others, dy-
namic linearity range are capable of covering the therapeutic
purposes. The proposed electrode is rapid, simple, inexpensive,
and sensitive enough for determination of DOX in spiked human
plasma.4. Conclusions
We have illustrated that GQD-GCE offers a stable low-potential
voltammetric detection of DOX. The GQD-coating allows a marked
decrease in the overvoltage for DOX oxidation. Such electroactivity
and stability compare favourably to that observed in other elec-
trode modiﬁer materials. The proposed sensor was used for in-
vestigation of DOX in human plasma without a necessity for
sample pre-treatment or any time-consuming extraction and
evaporation steps prior to the analysis with satisfactory recovery.
Additional studies are required for understanding the unique be-
havior of GQD-modiﬁed electrodes towards bioanalysis.Acknowledgments
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